Companies

Overview of companies on the stock market

Salesforce shares fell by 6% after quarterly report

Salesforce CRM developer releases Q3 2022 report. Results exceeded expectations, but the company gave a weak outlook for the next quarter. Shares fell by 6%, to 267 $. Salesforce is a set of cloud services for working with clients.

What investment banks and investors say about the new strain of "omicron"

Since last Friday, the new strain of COVID-19 “omicron” has been the main topic of discussion in the stock market. CNBC interviewed major banks and found out, what is the risk?, in their opinion, carries "omicron" for investors. Many learned about the strain 26 november, when WHO convened an urgent meeting.

Generac Holdings Review: Generators, hurricanes and high cost

Generac Holdings (NYSE: GNRC) - American manufacturer of generators. The company has a stable business with good market conditions. But the stock looks overbought, And, it seems to me, all the positive is already included in the current price. When creating the material, sources were used, inaccessible to users from the Russian Federation. We hope, Do you know, what to do.

Very Hard Drives: Western Digital Review

Western Digital (NASDAQ: WDC) - American manufacturer of high-tech products. Thanks to the shortage of semiconductors, the company increased the margins of the business, but her old problems have not gone away. When creating the material, sources were used, inaccessible to users from the Russian Federation. We hope, Do you know, what to do.

PhosAgro Review: phosphates and complex fertilizers

Phosagro (LIFE: PHOR) is the world market leader in the production and supply of complex fertilizers with phosphorus content, apatite and nepheline concentrates. The group is the leader in the Russian market in terms of supplies of all types of fertilizers.

Gossamer Bio Review: not "goose", a biotech

Gossamer Bio (NASDAQ: GOSS) - a young biotech company from California. The business was founded in 2015 and went public in 2019 through a nasdaq offering. The company focuses on the development of drugs in the field of immunology, oncology and therapy of inflammatory processes.

Investment banks lower the target for Alibaba shares by record 18 weeks

Since August, the consensus forecast for the company's shares has decreased from 280 to 200 $. But only one analyst from the 52. First, regulators Analysts began to reduce the target for Alibaba shares in the summer. Then the Chinese authorities tightened control over large companies, such as Tencent, DiDi и TAL Education.

Scroll to Top